Individualized Medication Guidance for Prostate Cancer
This test detects 346 genes, including HRR pathway genes. The content involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for prostate cancer patients.
Features of Individualized Medication Guidance for Prostate Cancer DiagnosisTargeted therapy-Including SNV, InDel, CNV and gene rearrangement, comprehensively guide targeted drug use.
Immunotherapy-Detect TMB and MSI indicators, as well as positive and negative immune-related genes, provide information to guide immunosuppressive therapy.
Chemotherapy- Detect chemotherapeutic drug loci associated with prostate cancer, suggesting sensitivity and toxic side effects of chemotherapeutic drugs.
Hereditary risk assessment- Covering HRR pathway genes, suggesting pathogenic and suspected pathogenic variants, guiding PARP inhibitor therapy, and suggesting genetic risk based on family tumor history and other information.
Applicable Population of Individualized Medication Guidance for Prostate Cancer Prognosis, Prostate Cancer Prevention, Prostate Cancer Therapy
Prostate cancer patients who have relapsed, drug-resistant problem.
Prostate cancer patients who have been diagnosed with prostate cancer, and need liquid biopsy for targeted therapy and immunotherapy.
Late-stage newly diagnosed prostate cancer patients who need targeted therapy and immunotherapy.
If you want to know more details of chemotherapy for prostate cancer, please visit our website.
As an ivd in vitro diagnosticcompany, we can offer sorts of ivd in vitro diagnosticequipment for sale, if you are interested, please leave us a message.
Отправить запрос, связаться с поставщиком
Другие товары поставщика
 |
Clinical WES | At present, there are more than 20,000 human genes have been discovered, with a total of more than 180,000 exons. Genes are composed of exons and i... |
 |
Individualized Medication Guidance for Cancer (118 Genes) | This cancer genetic testdetects 136 genes, including 110 targeted drug-related genes and 27 chemotherapy drug-related genes, provides the correlati... |
 |
CapitalBio® Microarray Hybridization Station | CapitalBio® Microarray Hybridization Station The CapitalBio® BioMixerTMII is a microarray hybridization station that uses continuous 3-D m... |
 |
CNV-seq Detection (Semiconductor Sequencing) | The detection kit, which is based on the BES 4000 platform, is used to perform low-depth whole-genome sequencing of DNA. The sequencing results are... |
|
|
Individualized Medication Guidance for Prostate Cancer | This test detects 346 genes, including HRR pathway genes. The content involves targeted therapy, immunotherapy, chemotherapy and hereditary risk as... |
Похожие товары
 |
Suzhou Piaozhihua Composite Material Technology Co., Ltd. | Продавец: Suzhou Piaozhihua Composite Material Technology Co., Ltd. | Piao Zhihua is a private company specializing in the production of high-grade self-adhesive label... |
 |
Distal Radius L-Shaped Locking Plate | Продавец: ATOM Medical Devices Co., Ltd | Model Number: 4062200 Material:Material: TA3G Pure titanium, TC4 titanium alloy Application: Fo... |
 |
Posterior Thoracolumbar Spinal System 5.5 | Продавец: ATOM Medical Devices Co., Ltd | This Posterior Thoracolumbar Spinal System 5.5is a comprehensive posterior spinal fixation soluti... |
 |
Lumbar Interbody Fusion Cage(Insert-Type) | Продавец: ATOM Medical Devices Co., Ltd | The Uni-L self-stabilizing lumbar interbody fusion cageis a PEEK (polyetheretherketone) device fe... |
 |
Anterior Cervical Plate - Type II | Продавец: ATOM Medical Devices Co., Ltd | Model Number: 1010002 Material: Titanium alloy TC4 Application: Anterior internal fixation duri... |
